D'AMBROSIO, Lorenzo

D'AMBROSIO, Lorenzo  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 51 (tempo di esecuzione: 0.304 secondi).
Titolo Data di pubblicazione Autore(i) File
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST) 2023 Cappello, Giovanni; Giannini, Valentina; Cannella, Roberto; Tabone, Emanuele; Ambrosini, Ilaria; Molea, Francesca; Damiani, Nicolò; Landolfi, Ilenia; Serra, Giovanni; Porrello, Giorgia; Gozzo, Cecilia; Incorvaia, Lorena; Badalamenti, Giuseppe; Grignani, Giovanni; Merlini, Alessandra; D'Ambrosio, Lorenzo; Bartolotta, Tommaso Vincenzo; Regge, Daniele
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 2012 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 2012 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report 2017 D'Ambrosio, Lorenzo; Palesandro, Erica; Moretti, Marina; Pelosi, Giuseppe; Fabbri, Alessandra; Carnevale Schianca, Fabrizio; Aglietta, Massimo; Grignani, Giovanni
Anticoagulation for central venous catheters in patients with cancer. 2014 D'Ambrosio L;Aglietta M;Grignani G
Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors 2021 Cannella R.; Tabone E.; Porrello G.; Cappello G.; Gozzo C.; Incorvaia L.; Grignani G.; Merlini A.; D'Ambrosio L.; Badalamenti G.; Regge D.; Bartolotta T.V.
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 2018 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature. 2014 Rota Scalabrini D;Caravelli D;Carnevale Schianca F;D'Ambrosio L;Tolomeo F;Boccone P;Manca A;De Rosa G;Nuzzo A;Aglietta M;Grignani G
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity? 2011 Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G.
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 2020 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 2018 Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 2014 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study 2023 Bon, Giulia; Krasniqi, Eriseld; Porru, Manuela; D'Ambrosio, Lorenzo; Scalera, Stefano; Maugeri-Saccà, Marcello; Di Lisa, Francesca Sofia; Filomeno, Lorena; Arcuri, Teresa; Botticelli, Andrea; Santini, Daniele; Fabbri, Maria Agnese; D'Auria, Giuliana; Pulito, Claudio; Blandino, Giovanni; Marchio', Caterina; Barba, Maddalena; Ciliberto, Gennaro; Vici, Patrizia; Pizzuti, Laura
Delving into PARP inhibition from bench to bedside and back 2020 Grignani G.; Merlini A.; Sangiolo D.; D'Ambrosio L.; Pignochino Y.
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 2022 Alessandra Merlini, Maria Laura Centomo, Giulio Ferrero, Giulia Chiabotto, Umberto Miglio,Enrico Berrino, Giorgia Giordano, Silvia Brusco, Alberto Pisacane, Elena Maldi, Ivana Sarotto,Federica Capozzi, Cristina Lano, Claudio Isella, Giovanni Crisafulli, Massimo Aglietta,Angelo Paolo Dei Tos, Marta Sbaraglia,Dario Sangiolo, Lorenzo D’Ambrosio, Alberto Bardelli, Ymera Pignochino, Giovanni Grignani
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group 2020 D'Ambrosio, Lorenzo; Touati, Nathan; Blay, Jean-Yves; Grignani, Giovanni; Flippot, Ronan; Czarnecka, Anna M; Piperno-Neumann, Sophie; Martin-Broto, Javier; Sanfilippo, Roberta; Katz, Daniela; Duffaud, Florence; Vincenzi, Bruno; Stark, Daniel P; Mazzeo, Filomena; Tuchscherer, Armin; Chevreau, Christine; Sherriff, Jenny; Estival, Anna; Litière, Saskia; Sents, Ward; Ray-Coquard, Isabelle; Tolomeo, Francesco; Le Cesne, Axel; Rutkowski, Piotr; Stacchiotti, Silvia; Kasper, Bernd; Gelderblom, Hans; Gronchi, Alessandro
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas 2021 Kantidakis, Georgios; Litière, Saskia; Neven, Anouk; Vinches, Marie; Judson, Ian; Schöffski, Patrick; Wardelmann, Eva; Stacchiotti, Silvia; D'Ambrosio, Lorenzo; Marréaud, Sandrine; van der Graaf, Winette T A; Kasper, Bernd; Fiocco, Marta; Gelderblom, Hans
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 2021 Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y.
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets 2024 Merlini, Alessandra; Rabino, Martina; Brusco, Silvia; Pavese, Valeria; Masci, Debora; Sangiolo, Dario; Bironzo, Paolo; Scagliotti, Giorgio Vittorio; Novello, Silvia; D'Ambrosio, Lorenzo
Eribulin-based treatment in patients affected by sarcomas: a case series 2020 Grignani, Giovanni; D'Ambrosio, Lorenzo